Study of SHR-7787 injection plus other cancer drugs for solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial is testing a new drug, SHR-7787, combined with other cancer treatments for people with advanced solid tumors that cannot be removed by surgery. The goal is to see if this combination can help shrink or control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced solid tumors that cannot be removed by surgery
- You have at least one tumor that can be measured on scans
- You are able to do daily activities with little or no help (ECOG 0 or 1)
- Your organs are working well enough, as confirmed by blood tests
- Your life expectancy is at least 3 months
- You have not had active brain metastases, other cancers in the last 5 years, or serious infections
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SHR-4849 combined with other anticancer medications in people with advanced solid tumors. The goal is to see if this combination is safe and effective.
This study tests a new drug called SHR-4298 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective.
This trial is testing an investigational drug called SHR-7787 for people with advanced solid tumors (cancer that has spread or can't be removed). The goal is to see if it is safe and how well it works. It may be an option if your tumor type is no longer responding to other treatments.
This trial tests a new drug called SHR-7782 for people with advanced cancers that have not responded to other treatments. It aims to see if the drug is safe and can shrink tumors.
This trial tests a new drug called SHR-3821 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective.
This study tests a new drug called SHR-4375 combined with other cancer treatments for people with advanced solid tumors that haven't gotten better with standard care. The goal is to see if the combination is safe and works against the cancer.
Hear when a new Malignant Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.